Terns Pharmaceuticals, Inc. (TERN)
NASDAQ: TERN · Real-Time Price · USD
8.62
-0.89 (-9.36%)
Sep 13, 2024, 11:48 AM EDT - Market open
Terns Pharmaceuticals Revenue
Revenue (ttm)
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
66
Market Cap
610.48M
Revenue Chart
Revenue History
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Community Health Systems | 12.55B |
| Alphatec Holdings | 540.28M |
| Cytek Biosciences | 197.71M |
| Weave Communications | 187.00M |
| OrthoPediatrics | 175.07M |
| Standard BioTools | 136.30M |
| Wave Life Sciences | 110.50M |
| ABIVAX Société Anonyme | 9.70M |
TERN News
- 16 hours ago - Terns Announces Closing of Public Offering of Shares of Common Stock and Pre-Funded Warrants, Including Full Exercise of Underwriters' Option to Purchase Additional Shares - GlobeNewsWire
- 2 days ago - Terns Announces Pricing of Upsized $150.15 Million Public Offering - GlobeNewsWire
- 3 days ago - Terns Pharmaceuticals: Weight Loss Drug TERN-601 Is Competitive - Seeking Alpha
- 3 days ago - Terns Announces Proposed Public Offering - GlobeNewsWire
- 4 days ago - Terns Pharmaceuticals Stock Is Soaring on Good Data for Weight-Loss Pill - Barrons
- 4 days ago - Top 2 Health Care Stocks That May Collapse This Quarter - Benzinga
- 4 days ago - Terns Pharmaceuticals' stock soars 30% after biotech posts positive results in trial of weight-loss drug in pill form - Market Watch
- 4 days ago - Terns Pharmaceuticals' oral obesity drug cuts weight by 4.9% in early study - Reuters